Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1812 | 0.4169 | 0.4169 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0098 | 0.0062 | 0.0062 |
Mycobacterium leprae | Possible phosphoglycerate mutase | 0.0072 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.4175 | 0.9828 | 0.9828 |
Onchocerca volvulus | 0.0124 | 0.0124 | 0.0124 | |
Mycobacterium tuberculosis | Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) | 0.0072 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0139 | 0.016 | 0.016 |
Plasmodium vivax | phosphoglucomutase-2, putative | 0.0072 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0072 | 0 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.4175 | 0.9828 | 0.9828 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4175 | 0.9828 | 0.9828 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.0124 | 0.0124 |
Echinococcus multilocularis | geminin | 0.0139 | 0.016 | 0.016 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.1812 | 0.4169 | 0.4169 |
Brugia malayi | hypothetical protein | 0.0124 | 0.0124 | 1 |
Mycobacterium leprae | probable isochorismate synthase EntC | 0.0072 | 0 | 0.5 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.2506 | 0.5831 | 1 |
Schistosoma mansoni | 6-phosphofructokinase | 0.4247 | 1 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0072 | 0 | 0.5 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0072 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.2506 | 0.5831 | 1 |
Mycobacterium tuberculosis | Glucosyl-3-phosphoglycerate phosphatase GpgP | 0.0072 | 0 | 0.5 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0072 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0072 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4247 | 1 | 1 |
Plasmodium falciparum | phosphoglucomutase-2 | 0.0072 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2435 | 0.566 | 0.566 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0072 | 0 | 0.5 |
Toxoplasma gondii | phosphoglycerate mutase PGMII | 0.0072 | 0 | 0.5 |
Mycobacterium tuberculosis | PE-PGRS family protein PE_PGRS11 | 0.0072 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE PHOSPHOGLYCERATE MUTASE 1 GPM1 (PHOSPHOGLYCEROMUTASE) (PGAM) (BPG-DEPENDENT PGAM) | 0.0072 | 0 | 0.5 |
Plasmodium falciparum | phosphoglycerate mutase, putative | 0.0072 | 0 | 0.5 |
Onchocerca volvulus | 0.4247 | 1 | 1 | |
Toxoplasma gondii | phosphoglycerate mutase | 0.0072 | 0 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4247 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0139 | 0.016 | 0.016 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4247 | 1 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0072 | 0 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0072 | 0 | 0.5 |
Treponema pallidum | phosphoglyceromutase | 0.0072 | 0 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.2506 | 0.5831 | 0.5 |
Echinococcus granulosus | geminin | 0.0139 | 0.016 | 0.016 |
Mycobacterium leprae | Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) | 0.0072 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0072 | 0 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.2506 | 0.5831 | 0.5 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0072 | 0 | 0.5 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0072 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.4247 | 1 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0072 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE PHOSPHOGLYCERATE MUTASE (PHOSPHOGLYCEROMUTASE) | 0.0072 | 0 | 0.5 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0072 | 0 | 0.5 |
Chlamydia trachomatis | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase | 0.0072 | 0 | 0.5 |
Plasmodium vivax | phosphoglycerate mutase, putative | 0.0072 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.4175 | 0.9828 | 0.9828 |
Mycobacterium tuberculosis | Possible phosphoglycerate mutase Gpm2 (phosphoglyceromutase) (PGAM) (BPG-dependent PGAM) | 0.0072 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.4175 | 0.9828 | 0.9828 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0098 | 0.0062 | 0.0062 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1812 | 0.4169 | 0.4169 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.4247 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.4247 | 1 | 1 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.2506 | 0.5831 | 1 |
Mycobacterium tuberculosis | Probable conserved lipoprotein LpqD | 0.0072 | 0 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0098 | 0.0062 | 0.5003 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0072 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0072 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible hydrolase MutT1 | 0.0072 | 0 | 0.5 |
Mycobacterium leprae | POSSIBLE HYDROLASE MUTT1 | 0.0072 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1812 | 0.4169 | 0.4169 |
Trichomonas vaginalis | phosphoglycerate mutase, putative | 0.0072 | 0 | 0.5 |
Toxoplasma gondii | phosphoglycerate mutase family protein | 0.0072 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Control (functional) | = 157 % | Increase in the accumulation of vincristine in multi-drug resistant GC3/Cl (human adenocarcinoma) cell line in vitro. | ChEMBL. | 1527786 |
Control (functional) | = 280 % | Increase in the accumulation of vincristine in multi-drug resistant KB8-5 (HeLa variant) cell line in vitro. | ChEMBL. | 1527786 |
Control (functional) | = 280 % | Increase in the accumulation of vincristine in multi-drug resistant KB8-5 (HeLa variant) cell line in vitro. | ChEMBL. | 1527786 |
Control (functional) | = 426 % | Increase in the accumulation of vinblastine in multi-drug resistant GC3/Cl (human adenocarcinoma) cell line in vitro. | ChEMBL. | 1527786 |
Control (functional) | = 776 % | Increase in the accumulation of vinblastine in multi-drug resistant KB8-5 (HeLa variant) cell line in vitro. | ChEMBL. | 1527786 |
Control (functional) | = 776 % | Increase in the accumulation of vinblastine in multi-drug resistant KB8-5 (HeLa variant) cell line in vitro. | ChEMBL. | 1527786 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.